Protective activity of the antilipopolysaccharide antibodies from human cord serum by Pontes, Gerlandia Neres et al.
Protectiveactivityoftheantilipopolysaccharideantibodies from
human cord serum
Gerlaˆndia Neres Pontes1, Silvia GomesMassironi1, Christina Arslanian1, Dora Lisa Friedlander-Del Nero2,
Magda Maria Sales Carneiro-Sampaio3 & Aparecida Tiemi Nagao4
1Department of Immunology, Institute of Biomedical Sciences, Universidade de Sa˜o Paulo, Sa˜o Paulo, SP, Brazil; 2Department of Parasitology, Institute of
Biomedical Sciences, Universidade de Sa˜o Paulo, Sa˜o Paulo, SP, Brazil; 3Department of Pediatrics, Medical School, Universidade de Sa˜o Paulo, Sa˜o Paulo,
SP, Brazil; and 4Department of Clinical Analysis and Toxicology, Universidade Federal do Ceara´, Sa˜o Paulo, Brazil
Correspondence: Gerlaˆndia Neres Pontes,
Laborato´rio de Imunologia de Mucosas,
Instituto de Cieˆncias Biome´dicas, Av. Lineu
Prestes, 1730, CEP 05508-900, Sa˜o Paulo, SP,
Brazil. Tel.:155 11 30917435; fax:155 11
30917224; e-mail: gepontes@usp.br
Received 20 October 2005; revised 20 March
2006; accepted 28 March 2006.
First published online 26 May 2006.
doi:10.1111/j.1574-695X.2006.00107.x
Editor: Patrik Bavoil
Keywords
Escherichia coli O6; sepsis; maternally acquired
immunity; proinflammatory cytokines;
antilipopolysaccharide antibodies.
Abstract
We evaluated the ability of human maternal and cord serum antibodies to protect
mice challenged with live Escherichia coli serotype O6:K2ac (E. coli O6). Mice
received paired maternal or cord serum pools before a challenge with E. coli O6 to
evaluate the mortality rate. All the pools were able to protect the animals
challenged with bacteria except the test group from paired maternal and cord sera
from preterm neonates containing less than 1.0 mg L1 immunoglobulin G anti-
body levels. In liver, spleen and mesenteric lymph nodes from the control group
(phosphate–buffered saline), more than 102 CFU mL1 bacteria were found at
30 min and more than 105 CFU mL1 after 120 min. The test group showed lower
bacterial counts in the organs, and no bacteria in the mesenteric lymph nodes
during the evaluated period. Tumor necrosis factor alpha and interleukin 6 were
undetectable in serum from animals pretreated with paired maternal and cord
serum pools from full-term neonates and pools from preterm neonates containing
high antibody and avidity levels. Our findings suggest that placental transfer of
antilipopolysaccharide O6 immunoglobulin G antibodies to neonates has a high
capacity to prevent lethal infection with E. coli O6 in a mouse protection model
and that the degree of protection is determined by the concentration and avidity of
these IgG antibodies.
Introduction
Gram-negative bacteria are prevalent in the maternal canal
and can colonize infants before or during delivery (Klein
et al., 2000). Escherichia coli, especially serotypes O4, O6, O7
and O16, are frequently isolated from blood samples of
newborns with sepsis (McCabe et al., 1978; Cross et al.,
1984; Kuseceket et al., 1984; Dias et al., 1994). The type of
effect is determined by several factors including the viru-
lence of the organisms, the size of the inoculum, and host
nutritional status, age and prematurity (Hotchkiss & Karl,
2003). Despite advances in neonatal management, systemic
bacterial infections remain an important cause of morbidity
and mortality in infants, especially among low birthweight
infants (Ng, 2004).
The interaction between lipopolysaccharide (LPS) and
mononuclear cells does not injure host tissues directly but
rather through the action of induced endogenous mediators
of inflammation (Klein et al., 2000). Macrophages stimu-
lated by LPS, in the presence of high levels of C5a, showed
enhanced production of tumor necrosis factor alpha (TNF-
a) and interleukin 6 (IL-6), which could be related to cell
damage (Ward, 2004). Increased susceptibility to sepsis in
the neonates has been attributed to the lack of maternal
anti-LPS antibodies, supposed to be only of the immuno-
globulin M (IgM) isotype, according to current literature
(Lewis & Wilson, 1995), which could partially explain the
susceptibility of newborns to Gram-negative bacterial infec-
tions. Previous studies by our group demonstrated the
existence of placental transfer of anti-LPS immunoglobulin
G (IgG) antibodies, reactive not only to the O chain, but also
against the core and lipid A (Nagao et al., 1998, 2001).
Chemically extracted LPS is frequently used in animal
models to study human endotoxemia (Ge et al., 1994). It was
demonstrated that the cellular localization differs when pur-
ified LPS compared with viable bacteria are injected (Ge et al.,
1994). The findings raised the question of whether studies
utilizing purified LPS preparations to verify biological activ-
ities in animal models could truly reproduce the biological
properties of LPS released from live bacteria (Ge et al., 1994).
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Selective breeding of mice from outbred stock was carried
out for quantitative antibody response to flagellar and
somatic antigens of salmonellae (Mice Selection III) (Si-
queira et al., 1976). At the selection limit, this selection
produced homozygous high (HIII) and low (LIII) responder
lines for the character investigated – the peak agglutinin
response to optimal secondary immunization (Sant’anna
et al., 1989). This phenotype was shown to be controlled by
approximately seven independent loci expressing themselves
at several distinct cellular levels (Sant’anna et al., 1989).
Several quantitative trait loci, which regulate antibody
production against many other antigens, were demonstrated
recently. These two lines of mice have shown strong biolo-
gically significant differences, as the interline difference in
antibody levels was not restricted to the antigen used for the
selection (multispecific effect) and were associated with
modifications in resistance to infections and experimental
arthritis, longevity and tumor incidence (Sant’anna et al.,
1989; Souza et al., 2004).
Considering a putative role of anti-LPS antibodies as the
basis for immunoprophylaxis or immunotherapy for Gram-
negative sepsis (Pollack, 1999), we speculated whether the
cord serum antibody repertoire, which obviously represents
maternal IgG, would be able by itself to protect inbred HIII
mice from a challenge with live E. coli O6.
Materials and methods
Serum samples
Blood samples were collected from healthy, well-nourished
mothers aged 18–35 years and cord blood samples from
their respective newborn infants, after informed consent. All
mothers and infants were selected from among those cared
for at the Hospital Maternidade Cachoeirinha, Sa˜o Paulo,
Brazil. Most of the mothers lived under poor socioeconomic
and hygiene conditions. Twenty-four newborn infants were
full-term and adequate for gestational age and 12 were
preterm infants under 37 weeks of gestational age. After
blood collection, serum samples were obtained and kept at
20 1C until analysis. The project was approved by the Ethics
Committee for Human Research (ECHR), Instituto de Cieˆn-
cias Biome´dicas/Universidade de Sa˜o Paulo – on 06/16/1998.
Bacteria
Escherichia coli (serotype O6 : K2ac : H1) was provided by
the Center of Culture Collection, Gothenburg, Sweden.
LPS extraction
LPS was extracted with hot phenol by the method
of Westphal & Jann (1965). Briefly, a 20 L culture of
E. coli O6 : K2ac : H1 was obtained and submitted to cen-
trifugation at 10 000 g for 30 min (Sorvall superspeed
RC2-B, Reston, VA). The pellet was washed twice in acetone and
frozen at  70 1C. The bacterial paste (29 g) was dissolved in
distilled water, warmed to 67 1C and mixed (v/v) with pre-
warmed phenol (Merck, Germany). The mixture was shaken
vigorously for 15 min, cooled and centrifuged at 18 000 g for
15 min. The aqueous phase was recovered and re-extracted
twice more with phenol. The final suspension was exten-
sively dialyzed against distilled water and LPS was precipi-
tated by the addition of ethyl alcohol to a final concentration
of 80%. The precipitate was recovered by centrifugation at
18 000 g for 15 min. After re-suspension in distilled water,
the solution was ultracentrifuged at 100 000 g for 4 h and the
final pellet was lyophilized and tested for protein and nucleic
acid content. This preparation contained less than 1%
nucleic acid and 2.1% proteins.
Animals
Inbred male HIII (high III) mice, six to eight weeks old
(kindly donated by Dr Maria Siqueira, Butantan Institute,
Sa˜o Paulo, Brazil), selected for high susceptibility to infec-
tion with Salmonella typhimurium (Siqueira et al., 1976;
Sant’anna et al., 1989; Souza et al., 2004) were used. The
HIII selection of mice began in 1976, done by Dr Maria
Siqueira as an outbred selection for high susceptibility to S.
typhimurium infection (Sant’anna et al., 1989). In 1997, the
inbreeding process began, and after 14 generations, the HIII
mice were transferred to an isolator, where the inbreeding
process continued. Today, it is in the F36 generation of
inbreeding (Cabrera, WHK, Instituto Butantan, Sa˜o Paulo,
Brazil, pers. comm.).
The project was approved by the Ethics Committee for
Animal Research (ECAR), Instituto de Cieˆncias Biome´dicas/
Universidade de Sa˜o Paulo.
Enzyme-linked immunosorbent assay (ELISA)
for antibody levels
Microtiter plates (Costar) were coated with 10 mg L1 of
purified LPS O6 diluted in phosphate-buffered saline (PBS),
100 mL per well. After blocking the plates with 5% fish
gelatin (Sigma, St Louis, MO), the reference standards for
serum IgG, IgM and immunoglobulin A (IgA) antibody
isotypes, paired maternal and cord serum samples diluted to
1 : 50 in PBS-0.5 M NaCl-0.2% Tween 20, were incubated in
duplicate in the wells at 4 1C overnight. After washing with
PBS-0.5 M NaCl-0.2% Tween 20, plates were incubated with
horseradish peroxidase-conjugated goat anti-human IgG,
IgM or IgA (Sigma) for 2 h at 37 1C. The substrate solution
containing 0.4 mg orthophenylenediamine per mL citrate-
phosphate buffer 0.1 M at pH 5.0 was added to the plates.
After 30 min incubation, the enzymatic reaction was
stopped with 50 mL of 2.5 N H2SO4. Absorbances were read
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in a microplate reader at 492 nm (Labsystems Multiskan
MS, Farnborough, Hampshire, UK). A pool of blood donor
serum samples, included in the assays for anti-LPS IgG, IgM
and IgA antibody measurements, were used as second
reference standards. The concentrations of the standards
were determined according to the procedure reported by
Fomsgaard (1990). Purified human IgG and IgA (codes I-
8640 and I-2636, Sigma) and a commercial human serum
sample for IgM values (catalog 552, Kallestad, MI) were used
as primary reference standards. After analysis, the sera were
pooled according to the total maternal antibody levels. The
concentrations of anti-LPS O6 IgG, IgM and IgA antibodies
were then determined in the pools from paired maternal and
cord serum.
ELISA for antibody avidities
The serum antibody avidities of the pools from paired
maternal and cord serum were determined using potassium
thiocyanate to elute bound complexes (Jones et al., 1987).
Microtiter plates (Costar) were coated with 10 mg L1 of
purified LPS O6 diluted in phosphate buffered saline (PBS),
100 mL per well. After blocking the plates with 5% fish
gelatin (Sigma), the pooled serum samples were diluted to
1 : 50 in PBS-0.5 M NaCl-0.2% Tween 20 (in duplicates),
and incubated overnight at 4 1C. After incubation and
washing, 0.1 mL potassium thiocyanate (0.0, 0.10, 0.25, 0.5,
1.0, 2.0, 3.0 and 4.0 M) in PBS-0.5 M NaCl-0.2% Tween 20
were added to the wells. After 30 min, the plates were washed
six times and incubated for 2 h with horseradish peroxidase-
conjugated goat anti-human IgG, IgA or IgM (Sigma). The
plates were washed three times and incubated with 0.1 mL of
the substrate solution. The results were expressed as the
molarity of potassium thiocyanate necessary to elute 50% of
the bound complexes.
Animal model
The lethal dose 100 (LD100) of the bacteria was determined
by challenging adult HIII mice with viable E. coli O6
(1 106 to 7 106 CFU per animal) intraperitoneally. The
number of dead animals was assessed at regular intervals
over a period of 72 h.
Protective experiments with maternal and
cord serum pools from full-term or preterm
neonates
Adult HIII mice were injected intraperitoneally with 0.4 mL
of paired maternal or cord serum pools from full-term or
preterm neonates containing high or low levels of anti-LPS
O6 antibodies (test groups) or with PBS (control groups)
18 h before being challenged intraperitoneally with 3 106
viable E. coli O6 CFU per animal. Survival of the animals was
assessed at regular intervals over a period of 72 h. For organ
extraction, some animals were sacrificed 24 h after the
challenge and the organs were submitted to microbiological
and histochemical analysis.
Microbiological analysis
Brain, spleen, heart, liver and mesenteric lymph nodes from
the control and test groups were removed by using a sterile
aseptic technique, weighed, and homogenized in 8 mL of
Brain Heart Infusion (BHI, Difco, Detroit, MI). A 10 mL
volume of a 104 dilution of each extract was cultivated onto
BHI agar (Difco) plates. After 18 h incubation at 37 1C, the
number of bacteria was estimated.
Histochemical analysis
Livers from the control and test groups were left in 5%
formaldehyde solution for 24 h and then embedded in 70%
ethanol and paraffin. The blocks were cut into 3–5 mm
sections and transferred to microscope slides. In addition
to the routine hematoxylin and eosin staining, the sect-
ions were stained for Ziehl-Neelsen stain to identify E. coli
O6. The sections were analyzed at 1000magnification
under a light (Zeiss, model LSM 510; Jena, Thuringia,
Germany).
Prevention of bacterial translocation
To evaluate the capacity of cord serum antibodies to prevent
bacterial translocation, HIII mice were injected intraperi-
toneally with 0.4 mL full-term cord serum pool containing
high levels of anti-LPS O6 antibodies 18 h before being
challenged with the live bacteria. Groups of four animals
were sacrificed every 30 min (30, 60, 90, 120 min) after the
challenge. Spleen, liver and mesenteric lymph nodes were
homogenized with 1 mL of sterile PBS. A 10 mL volume of a
104 dilution of each extract was cultivated on BHI agar
plates. After 18 h incubation at 37 1C, the colonies were
counted. Blood was collected from the animals by retro-
orbital puncture. Serum samples were tested for the pre-
sence of circulating human antibodies by ELISA.
IL-6 and TNF-a measurement in mouse serum
Adult mice (four per group) were injected intraperitoneally
with 0.4 mL paired maternal or cord serum samples from
full-term and preterm neonates, 18 h before being chal-
lenged with 10mg of LPS O6 per animal, intraperitoneally.
At 0, 2 and 6 h after the challenge, the mice were sacrificed
and blood was collected by retro-orbital puncture. Serum
levels of IL-6 and TNF-a were measured using ELISA
(Pharmingen, San Diego, CA).
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ELISA for cytokines
Microtiter plates (Costar) were coated with antimouse IL-6
or TNF-a antibodies (Pharmingen), diluted in 0.1 M carbo-
nate buffer, pH 9.5, and incubated overnight at 4 1C. After
washing with PBS-0.05% Tween, the plates were blocked
with PBS containing 10% fetal bovine serum for 1 h at room
temperature. After washing, serum samples from the ani-
mals and the reference standards were diluted with PBS-
10% fetal bovine serum, and incubated in duplicate over-
night at 4 1C. Samples were assayed at fourfold serial
dilutions starting at a dilution of 1 : 2. After washing with
PBS-0.05% Tween, the plates were incubated with 1 : 250
biotinylated antimouse IL-6 and antimouse TNF-a conju-
gates and the streptavidin-horseradish peroxidase conjugate
for 1 h at room temperature. After washing the plates, the
substrate solution containing 0.4 mg orthophenylenedia-
mine mL1 and 0.01% hydrogen peroxide in 0.1 M citrate-
phosphate buffer, pH 5.0, was added. After 30 min incuba-
tion, the enzymatic reaction was stopped by adding 50mL of
2.5 M H2SO4. Absorbances were read in a microplate reader
at 450 nm (Labsystem Multiskan MS, USA). The results
were determined using the GRAPHPAD PRISM 1.2 (San Diego,
CA) program and expressed in mg L1.
Statistical analysis
The non-parametric Wilcoxon test, Friedman test and
Spearman’s correlation were used for statistical analyses of
maternal and cord serum antibodies and serum pools. Data
concerning the mortality rates for animals grouped by anti-
LPS O6 IgG antibody concentrations were analyzed statisti-
cally by the Chi-squared test. IL-6 and TNF-a levels were
compared among groups by the Tukey test. The level of
significance was set at Po 0.05 in all analyses.
Results
Levels of anti-LPS O6 antibodies
Anti-LPS O6 antibody levels in maternal and cord serum
samples are shown in Table 1. Anti-LPS O6 IgG antibody
levels in cord serum from full-term newborns were similar
to their respective maternal IgG antibody levels (Wilcoxon
test, P4 0.1), and a significant correlation was found
between levels of IgG antibodies in mothers and neonates
(Spearman’s correlation, r= 0.85, Po 0.0001). Similar data
were obtained for preterm neonates and their respective
mothers (Wilcoxon test, P4 0.1, and Spearman’s correla-
tion, r= 0.81, P= 0.0004). Comparing concentrations of
different isotypes in maternal sera, anti-LPS O6 IgM levels
were significantly higher than the other antibody isotypes
(Friedman’s test, Po 0.0001, Table 1). Specific IgA levels
were not significantly different from the IgG antibody levels.
The formation of the pools was necessary because the
volume of the samples from maternal and cord was low and
each experiment utilized 0.4 mL per animal. Antibody
isotype levels were measured by ELISA and then grouped
according to the total maternal antibody levels. For the
formation of the pools, high antibody levels were hypothe-
tically considered to be above 20 mg L1. The only isotype
present in cord serum was IgG and therefore cord serum
samples were paired with maternal samples. Anti-LPS O6
IgG antibody levels in the pools of cord serum from full-
term and preterm neonates were similar to those of
the respective mothers and showed a strong correlation with
the maternal levels (Spearman test, Po 0.0001, r= 0.95,
Table 2). The avidity indexes of anti-LPS O6 in the pools of
cord serum from full-term and preterm neonates (Table 3)
did not differ from maternal antibody avidities (Wilcoxon
test, P= 0.45 and P= 0.30, respectively).
Animal model
For the animal model, HIII male mice were challenged with
1 106 (n= 5), 1.4 106 (n= 8), 3 106 (n= 8) and 7 106
(n= 8) CFU per animal of viable E. coli O6. All mice injected
with 3 106 and 7 106 CFU per animal of E. coli O6 died
between 18 and 24 h. The lethal dose 50 (LD50) was between
1 106 and 1.4 106, and the lethal dose 100 (LD100) could
be reached with 3 106 CFU per animal. Therefore, we
Table 1. Anti-LPS O6 antibody concentrations (mg L1) in maternal and
cord sera from their respective full-term and preterm neonates
Maternal serum Cord antibodies
IgA IgM IgG IgG
Full-term neonates
nw 24 24 24 24
Mean 1.6 17.4 1.6 1.5
SEM 0.1 2.9 0.5 0.5
Lower 95% CI 1.4 11.3 0.4 0.5
Upper 95% CI 1.9 23.5 2.7 2.5
Friedman test (P) o0.0001 o0.0001
Preterm neonatesz
n‰ 12 12 12 13
Mean 93.2 13.3 1.1 1.0
SEM 24.6 4.3 0.2 0.2
Lower 95% CI 36.5 3.8 0.5 0.5
Upper 95% CI 149.9 22.8 1.3 1.5
Friedman test (p) o0.0001 o0.0001
The only isotype present in cord serum was IgG.
wSerum samples from full-term newborn infants, adequate for gesta-
tional age and their respective mothers.
zThe results of samples 12 and 13 belong to the same mother that gave
birth to gemellary babies.
‰Serum samples from preterm newborn infants under 37 weeks of
gestational age and their respective mothers.
CI, confidence interval.
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established 3 106 CFU of viable bacteria per mouse as the
necessary dose to obtain a death rate of 100%.
Protective experiments with maternal and cord
serum pools from full-term or preterm neonates
All pools were able to protect the animals challenged
intraperitoneally with viable bacteria, except the maternal-
and cord serum pools from preterm neonates containing
IgG antibody levels below 0.9 mg L1, and the control group
(PBS), as shown in Figs 1 and 2. The microbiological
analysis of the spleen, brain, heart, liver, mesenteric lymph
nodes, lung and kidney from the animals revealed high
numbers of bacteria (41010 CFU) in the control group, but
a low number of bacteria (103 CFU) in the group which
had received cord serum from full-term neonates with high
antibody levels (Table 4). Histochemical analysis showed no
stained bacteria inside the hepatocytes of the animals
pretreated with serum from full-term and preterm neonates
containing high antibody levels, in contrast to the control
group, which showed hepatocytes completely invaded by the
bacteria (Fig. 3).
Prevention of bacterial translocation
The prevention of the dissemination of E. coli O6 from the
peritoneal cavity to sterile sites was evaluated at different
times after inoculation of the bacteria in the animals. Liver,
spleen and mesenteric lymph nodes from the control group
presented more than 102 bacterial CFU mL1 at 30 min and
more than 105 CFU mL1 after 120 min. The test group,
which had received cord serum from full-term neonates
with high antibody levels, showed significantly lower bacter-
ial counts (below 103 CFU mL1) in the organs, and no
bacteria in mesenteric lymph nodes during the period
evaluated (Fig. 4). To confirm the presence of the human
antibodies, mouse serum was collected at different times and
checked by ELISA. The serum sample presented 118.0mg L1
at 30 min, 125.0mg L1 at 60 min, 113.0mg L1 at 90 min and
130.0mg L1 at 120 min, of human anti-LPS O6 IgG anti-
bodies. The samples showed a mean concentration of
121.5mg L1 human IgG antibodies. No decay of the passively
transferred antibodies was observed during the time analyzed.
Detection of IL-6 and TNF-a in animal serum
IL-6 and TNF-a levels were measured by ELISA in sera from
animals challenged intraperitoneally with 10 mg of LPS O6
per mouse. As shown in Table 5, the cytokine levels in serum
from the animals treated with PBS did not differ signifi-
cantly from levels in serum from the animals pretreated with
paired maternal and cord sera from preterm neonates
containing low antibody levels (P4 0.05). On the other
Table 2. Levels of anti-LPS O6 antibodies in the pools of paired maternal
and cord serum from full-term and preterm neonates containing high
and low concentrations (mg L1) of antibodies. The serum samples were
grouped according to the maternal antibody levels
Maternal serum (mg L1)
Cord serum
(mg L1)w
IgA IgM IgG IgG
Full-term neonates
nz 24 24 24 24
High levels‰ 1.5 25.0 1.4 1.3
Low levelsw 0.8 13.2 1.1 0.9
Preterm neonates
nz 12 12 12 13
High levelsk 2.1 18.0 9.7 9.7
Low levels‰ 0.8 12.2 0.9 0.8
The levels of anti-LPS O6 antibody isotypes were determined by ELISA
and grouped according to the maternal antibody levels.
wThe only isotype present in cord serum was IgG.
zTwenty-four newborn infants were full-term and adequate for gesta-
tional age.
‰Low levels of anti-LPS O6 antibodies were hypothetically considered to
be below 20 mg L1 and cord serum samples were paired with maternal
samples.
zThirteen newborn infants were preterm infants under 37 weeks of
gestational age.
kHigh levels of anti-LPS O6 antibodies were hypothetically considered to
be above 20 mg L1 and cord serum samples were paired with maternal
samples.
Table 3. Anti-LPS O6 antibody avidities in pools of paired maternal
and cord serum from full-term and preterm neonates containing high
and low concentrations. The relative avidity indexes was expressed as
potassium thiocyanate molarities (M) necessary to elute 50% of the
bound complexes (antigen-specific antibodies) in ELISA
Maternal serum (m)
Cord serum
(m)w
IgA IgM IgG IgG
Full-term neonates
nz 24 24 24 24
High levels‰ 44.0 2.8 o4.0 44.0
Low levelsz 44.0 2.6 3.9 3.6
Preterm neonates
nk 12 12 12 13
High levels‰ 3.2 2.7 44.0 44.0
Low levelsz 44.0 2.8 2.7 3.3
The avidity indexes of the pooled antibodies were determined by ELISA
and cord serum samples were paired with maternal samples.
wThe only isotype present in cord serum was IgG.
zTwenty-four newborn infants were full-term and adequate for gesta-
tional age.
‰High levels of anti-LPS O6 antibodies were hypothetically considered to
be above 20 mg L1.
zLow levels of anti-LPS O6 antibodies were hypothetically considered to
be below 20 mg L1.
kThirteen newborn infants were preterm infants under 37 weeks of
gestational age.
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hand, the cytokines were undetectable in serum from
animals pretreated with paired maternal and cord serum
from full-term neonates and in serum from animals pre-
treated with paired maternal and cord serum from preterm
neonates containing high antibody levels (Po 0.001).
Discussion
A high prevalence of sepsis caused by enterobacteria such as
E. coli is observed during the neonatal period (Siegel &
McCracken, 1981). In a study conducted in Sa˜o Paulo,
Brazil, it was found that 6.4% of sepsis was caused by E. coli
(Brandileone et al., 1984). In another study, it was shown
that E. coli O6 serotype was frequently isolated in samples
from newborns with sepsis (Dias et al., 1994).
Based on our previous data showing that anti-LPS
O6 antibodies in cord blood were similar to those found
in the respective maternal serum samples (Nagao et al.,
1998), we questioned whether these antibodies would
be able to protect mice from the challenge with live E. coli
O6 strain.
Due to the small quantity of our serum samples for the
evaluation of protective capacity of the antibodies anti-LPS
O6 in mice challenged with live bacteria, these samples were
pooled according to the maternal antibody levels.
In the protective experiments, we demonstrated that all
mice that received the pool of cord serum from full-term
neonates containing 1.3 mg L1 of IgG antibodies and avid-
ity indexes above 4 M or the pool of cord serum from
preterm newborns containing 9.7 mg L1 of IgG antibodies
and avidity indexes above 4 M survived. The pool of cord
serum from full-term neonates containing 0.9 mg L1 IgG
antibodies and avidity indexes of 3.6 M protected 76% of the
animals, and the pool of cord serum from preterm new-
borns containing 0.8 mg L1 and IgG antibodies avidity
indexes of 3.3 M was able to protect only 50% of the
animals. This suggests that the differences in survival rates
did not depend on the IgM antibody concentrations, but on
the IgG antibody levels. These results agree with our recent
work (Pontes et al., 2005) showing that purified IgG
containing at least 1.0 mg L1 of anti-LPS O6 IgG antibodies
was able to protect mice from the challenge with viable
E. coli O6. Kim et al. (1988) demonstrated that lower
concentrations of anti-LPS O18 IgG antibodies (15- to
100-fold less than IgM) presented a high protection capacity
in rats challenged with O18:K1 E. coli.
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Fig. 1. Evaluation of the functional activity of human antibodies in
protecting animals from challenge with 3 106 CFU of viable Escherichia
coli O6 per mouse. The tested were paired maternal and cord serum pool
from full-term neonates containing high and low anti-LPS O6 IgG
antibody levels. Data concerning the mortality rates for animals grouped
by anti-LPS O6 IgG antibody concentrations were statistically analyzed by
the Chi-squared test. Results represent the standard deviation of 17
animals per group. Significant differences were considered at levels of
Po 0.05 in maternal and cord serum groups.
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Fig. 2. Evaluation of the functional activity of human antibodies in
protecting animals from challenge with 3 106 CFU of viable Escherichia
coli O6 per mouse. The tested samples were paired maternal and cord
serum pools from preterm neonates containing high and low anti-LPS
O6 IgG antibody levels. Data concerning the mortality rates for animals
grouped by anti-LPS O6 IgG antibody concentrations were statistically
analyzed by the Chi-squared test. Results represent the standard devia-
tion of 12 animals per group. Significant differences were considered at
levels of Po 0.05 in maternal and cord serum groups.
Table 4. Bacterial translocation in culture of organ extracts from male
HIII mice, injected with 0.4 mL of cord serum pool from full-term
neonates (Test group) or phosphate-buffered saline (Control group),
18 h before the challenge with viable Escherichia coli O6. For the
evaluation of the bacterial translocation, the animals were sacrificed
24 h after the challenge and the organs were homogenized, diluted to
104 in BHI broth and soon after, each extract was cultivated onto BHI
agar plates for 18 h at 37 1C. After incubation, the number of bacteria
was evaluated as CFU per organ
Organ Control groupw Test groupz
Spleen 3.61010 1 103
Brain 3.41010 2 101
Heart 3.21010 0
Liver 3.41010 1 103
Mesenteric lymph nodes 3.41010 0
Lung 3.01010 1 103
Kidney 3.21010 0
Bacterial culture of organ extracts from eight animals per group
challenged with viable 3106 CFU per mouse of E. coli O6.
wA 10mL volume of 104 dilution of each extract was cultivated on BHI
agar plates for 18 h at 37 1C, and the number of bacteria was evaluated
as CFU per organ.
zCord serum pool from full-term neonates containing high levels of
anti-LPS O6 antibodies.
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Sepsis in neonates can originate from the phenomenon of
virulent bacterial strains translocated from the gastrointest-
inal tract, or from other sites, to the bloodstream under
certain circumstances, reaching organs such as the liver and
the spleen (Schiff et al., 1993; Stuber, 1999; Ljungdahl et al.,
2000; Naaber et al., 2000). To check the translocation of
E. coli O6 : K2ac, the bacterial counts in the organ extracts
from animals pretreated with cord serum pool from full-
term neonates containing 1.3 mg L1 antibodies were ana-
lyzed: absent or low (below 104) numbers of CFU were
found. In contrast, analysis of the bacterial counts of the
control group showed high numbers of CFU, above 1010 in
all the analyzed organs. Our next step was to study the
progression of bacterial dissemination to the organs by
sacrificing a number of test and control animals every
30 min after the bacterial challenge. Within the first 30 min,
bacterial translocation to liver and spleen occurred in both
the test and control animals, whereas translocation to
mesenteric lymph nodes occurred only in the control group.
During the subsequent minutes, the rate of dissemination
(a)
(b)
Fig. 3. Histochemical analysis of the livers of mice challenged with
3106 CFU per animal of Escherichia coli O6, intraperitoneally 18 h
after having received cord serum pool from full-term neonates contain-
ing high levels of antibodies. Photomicrography shows a high number
only in the control group. (a) Control group (mice injected with PBS) – not
protected animals. (b) Test group (mice pretreated with cord serum from
full-term neonates containing high levels of anti-LPS O6 IgG antibody)
animals with previous injection of cord serum from full-term neonates
containing high levels of anti-LPS O6 IgG antibody. In addition to the
routine hematoxylin and eosin staining, the microscope slides were
stained for Ziehl-Neelsen stain to identify E. coli O6. The sections were
analyzed at 1000magnification under a light.
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Fig. 4. Analysis of bacterial translocation of the spleen, liver and
mesenteric lymph nodes from HIII mice challenged with 3106 CFU per
mouse of viable Escherichia coli O6 intraperitoneally 18 h after having
received cord serum pool from full-term neonates containing high levels
of anti-LPS O6 IgG antibodies. For the analysis, groups of four animals
were sacrificed every 30 min (30, 60, 90 and 120 min) after the
challenge. A 10 mL volume of a 104 dilution of each extract was
cultivated on BHI agar plates. After 18 h incubation at 37 1C, the number
of bacteria was evaluated as CFU per organ.
Table 5. Serum concentrations (mg L1) of TNF-a and IL-6 of animals
injected with maternal serum and cord serum pools from full-term and
preterm neonates containing high or low levels of anti-LPS O6 antibodies
or PBS, 18 h before being challenged with 10mg of LPS O6 per mouse.
Results represent the SE of four animals per group. Significant differ-
ences were considered at levels of Po 0.001 in maternal serum and
cord serum pools from full-term neonates containing high or low levels
of anti-LPS O6 antibodies and preterm neonates containing high levels of
anti-LPS O6 antibodies
Groupsw nz TNF-a‰,z IL-6‰,z
PBS 4 15.4 2.3 22.8 1.2
NPT low 4 7.2 0.2 6.8 0.5
MPT low 4 7.7 0.2 7.8 0.4
NPT high 4 0.0 0.0
MPT high 4 0.0 0.0
NT low 4 0.0 0.0
MT low 4 0.0 0.0
NT high 4 0.0 0.0
MT high 4 0.0 0.0
Po 0.001.
wM, maternal serum pool; N, cord serum pool; T, full-term; PT, preterm
pool; low, low levels of anti-LPS O6 antibodies, high, high levels of anti-
LPS O6 antibodies.
zn, number of animals tested per group.
‰At 2 h (TNF-a) and 6 h (IL-6) after the challenge with LPS O6, the mice
were sacrificed and blood was collected by retro-orbital puncture. Serum
levels of IL-6 and TNF-a were measured by ELISA.
zTNF-a and IL-6 levels were compared among groups by the Tukey test.
The results are expressed as mean SEM of cytokine levels.
FEMS Immunol Med Microbiol 47 (2006) 405–413 c 2006 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
411Human cord serum anti-LPS antibody protection
remained the same for the test group, i.e. around 102 in liver
and spleen, with no counts in mesenteric lymph nodes.
However, in the control group, the bacterial counts in-
creased logarithmically to more than 105 in the organs.
Similar results have been reported by Naaber et al. (2000).
These authors demonstrated that E. coli translocation from
the peritoneal cavity to heart blood, mesenteric lymph
nodes, liver, spleen, lung, heart muscle and kidney occurred
within 45 min after inoculation, reaching the highest rate
between 2 and 24 h after challenge with the bacteria (Naaber
et al., 2000).
The injection of LPS or bacteria (E. coli O55:B5) in animal
models or healthy volunteers results in excessive production
of proinflammatory cytokines. It is believed that in the
course of septic shock there is an excessive activation of the
inflammatory cascade resulting in endothelial injury, organ
injury and cardiovascular collapse (Kirsch & Giroir, 2000).
This inflammatory cascade occurs as a result of high
concentrations of C5a, enhancing the production of cyto-
kines (Schiff et al., 1993; Stuber, 1999; Ward, 2004). Taking
TNF-a and IL-6 as indicators of endotoxin shocks, we
observed that animals that had received serum pool from
full-term or preterm neonates containing 0.9 mg L1 and
0.8 mg L1 of anti-LPS O6 IgG antibodies, respectively, or
from their respective mothers before the challenge with LPS
O6, presented high levels of TNF-a and IL-6, similarly to the
control animals. In contrast, the animals protected with cord
serum from full-term neonates containing 1.3 mg L1 of anti-
LPS O6 IgG antibodies or preterm neonates with 9.7 mg L1
of anti-LPS O6 IgG antibodies did not show any detectable
proinflammatory cytokine in serum. These data agree with
another recent study which demonstrated that animals
protected with purified IgG from a pool of normal human
serum containing 1.1 mg L1 of anti-LPS O6 IgG antibodies
showed no detectable cytokines (Pontes et al., 2005).
The mothers included in the present study are at a low
socioeconomic level and live in houses with an adequate
water supply but an irregular sewage system, a factor that
increases the environmental exposure to microbes. The
immune response can be adapted to a large number of
environmental antigens by producing a greater amount of
antibodies than in the presence of low environmental
antigenic exposure (Nagao et al., 1993, 1995), even with
possible lower avidity (Roberton et al., 1988). According to
Zinkernagel (2001), high hygiene standards have reduced
the induction and maintenance of protective maternal
antibodies before pregnancy, which may consequently affect
maternally acquired immune protection.
In conclusion, we demonstrated that full-term and pre-
term neonate serum samples and their respective maternal
serum samples have a high capacity to protect animals from
death, depending on the concentration and avidity of anti-
LPS IgG antibodies. The model proposed in the present
study may be adequate for further investigations of the use
of gammaglobulins in sepsis. For this purpose, we suggest
selecting serum samples from healthy people containing IgG
antibody levels above 1.0 mg L1 and an avidity index above
4 M for the production of an appropriate intravenous
immunoglobulin preparation.
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